JP2006508993A5 - - Google Patents

Download PDF

Info

Publication number
JP2006508993A5
JP2006508993A5 JP2004554476A JP2004554476A JP2006508993A5 JP 2006508993 A5 JP2006508993 A5 JP 2006508993A5 JP 2004554476 A JP2004554476 A JP 2004554476A JP 2004554476 A JP2004554476 A JP 2004554476A JP 2006508993 A5 JP2006508993 A5 JP 2006508993A5
Authority
JP
Japan
Prior art keywords
formoterol
roflumilast
pharmaceutical
daily dose
time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004554476A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006508993A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/013266 external-priority patent/WO2004047828A1/en
Publication of JP2006508993A publication Critical patent/JP2006508993A/ja
Publication of JP2006508993A5 publication Critical patent/JP2006508993A5/ja
Pending legal-status Critical Current

Links

JP2004554476A 2002-11-27 2003-11-26 ロフルミラスト及び(r,r)−ホルモテロールを含有する新規の相乗組合せ Pending JP2006508993A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026504 2002-11-27
PCT/EP2003/013266 WO2004047828A1 (en) 2002-11-27 2003-11-26 Synergistic combination compresing roflumilas and (r.r) -formoterol

Publications (2)

Publication Number Publication Date
JP2006508993A JP2006508993A (ja) 2006-03-16
JP2006508993A5 true JP2006508993A5 (cg-RX-API-DMAC7.html) 2006-11-30

Family

ID=32338001

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004554476A Pending JP2006508993A (ja) 2002-11-27 2003-11-26 ロフルミラスト及び(r,r)−ホルモテロールを含有する新規の相乗組合せ

Country Status (31)

Country Link
US (1) US20060199865A1 (cg-RX-API-DMAC7.html)
EP (1) EP1567140B1 (cg-RX-API-DMAC7.html)
JP (1) JP2006508993A (cg-RX-API-DMAC7.html)
KR (1) KR20050094810A (cg-RX-API-DMAC7.html)
CN (1) CN1713902A (cg-RX-API-DMAC7.html)
AT (1) ATE399544T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003288169B8 (cg-RX-API-DMAC7.html)
BR (1) BR0316475A (cg-RX-API-DMAC7.html)
CA (1) CA2506956C (cg-RX-API-DMAC7.html)
CO (1) CO5690571A2 (cg-RX-API-DMAC7.html)
CY (1) CY1110368T1 (cg-RX-API-DMAC7.html)
DE (1) DE60321954D1 (cg-RX-API-DMAC7.html)
DK (1) DK1567140T3 (cg-RX-API-DMAC7.html)
EA (1) EA009990B1 (cg-RX-API-DMAC7.html)
ES (1) ES2309374T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20050580B1 (cg-RX-API-DMAC7.html)
IL (1) IL168307A (cg-RX-API-DMAC7.html)
IS (1) IS2576B (cg-RX-API-DMAC7.html)
MA (1) MA27538A1 (cg-RX-API-DMAC7.html)
ME (1) ME00488B (cg-RX-API-DMAC7.html)
MX (1) MXPA05005438A (cg-RX-API-DMAC7.html)
NO (1) NO334148B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ540658A (cg-RX-API-DMAC7.html)
PL (1) PL214869B1 (cg-RX-API-DMAC7.html)
PT (1) PT1567140E (cg-RX-API-DMAC7.html)
RS (1) RS51082B (cg-RX-API-DMAC7.html)
SI (1) SI1567140T1 (cg-RX-API-DMAC7.html)
TN (1) TNSN05130A1 (cg-RX-API-DMAC7.html)
UA (1) UA83017C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004047828A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200503307B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
EP1861074B1 (en) 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
CN103784443A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含沙美特罗和罗氟司特的药物组合产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
EP0938467B1 (en) * 1996-11-11 2002-06-12 Sepracor, Inc. Process for the preparation of optically pure isomers of formoterol
EA001758B1 (ru) * 1997-02-17 2001-08-27 Бык Гульден Ломберг Хемише Фабрик Гмбх Композиции для лечения респираторного дистресс-синдрома взрослых или респираторного дистресс-синдрома новорожденных, содержащие 3-(циклопропилметокси)-n-(3,5-дихлор-4-пиридинил)-4-(дифторметокси)бензамид и легочное поверхностно-активное вещество
US6333354B1 (en) * 1997-02-28 2001-12-25 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
EP1671651B1 (en) * 1999-08-21 2009-11-11 Nycomed GmbH Synergistic combination of pumafentrine and salmeterol
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ATE381537T1 (de) * 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilid-derivative als beta2-adrenorezeptor- agonisten
ES2314052T3 (es) * 2001-04-30 2009-03-16 Glaxo Group Limited Derivados de ester de 17beta-carbotioato de androstano con un grupo ester ciclico en la posicion 17alfa.

Similar Documents

Publication Publication Date Title
JP2022180461A5 (cg-RX-API-DMAC7.html)
US6790465B2 (en) Composition and method for treating snoring
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
RU2019100425A (ru) Новая доза и препаративная форма
JP2007520506A5 (cg-RX-API-DMAC7.html)
JP6762931B2 (ja) 経鼻組成物と該経鼻組成物の使用方法の改善
JP2014528474A5 (cg-RX-API-DMAC7.html)
CN108040468B (zh) 用于治疗口腔、咽喉和呼吸道疾病的制剂
TW202142232A (zh) 用於治療、改善或預防冠狀病毒感染之製品與方法
JP2005508963A5 (cg-RX-API-DMAC7.html)
JP2016138142A (ja) 大うつ病を有する患者において減量療法を提供する方法
JP2002528502A5 (cg-RX-API-DMAC7.html)
US3282778A (en) Medicinal preparation containing acetyl salicylic acid and a pyridoxine compound
RU2008119454A (ru) Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом
JP2016505050A5 (cg-RX-API-DMAC7.html)
JP2006508994A5 (cg-RX-API-DMAC7.html)
CN102772578B (zh) 一种用于治疗脚气的中药组合物
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
JP2006508993A5 (cg-RX-API-DMAC7.html)
JP2009534367A5 (cg-RX-API-DMAC7.html)
CN119700755A (zh) 化合物在制备预防和/或治疗高原病的药物中的应用
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
CA2506956A1 (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
WO2001062264A3 (en) Halotherapy method by inhalation of sodium chloride
Watanabe et al. Bronchodilator effects of nebulized fenoterol: a comparison with isoproterenol